5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 18597029)

Published in Photochem Photobiol Sci on April 21, 2008

Authors

Arnfinn Hykkerud Steindal1, Tran Thi Thu Tam, Xiao Yun Lu, Asta Juzeniene, Johan Moan

Author Affiliations

1: Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310, Oslo, Norway.

Articles by these authors

Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control (2004) 2.04

The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res (2009) 1.86

Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release (2008) 1.65

On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents (2004) 1.65

Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62

The importance of the depth distribution of melanin in skin for DNA protection and other photobiological processes. J Photochem Photobiol B (2006) 1.61

[Rhythms, depressions and light]. Tidsskr Nor Laegeforen (2006) 1.40

Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol (2009) 1.26

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer (2007) 1.21

The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int J Infect Dis (2010) 1.13

Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat (2006) 1.08

Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem Photobiol Sci (2007) 1.05

Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B (2005) 1.04

Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol (2008) 1.03

Ultraviolet photodegradation of folic acid. J Photochem Photobiol B (2005) 1.03

Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol (2007) 1.03

Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol (2008) 1.02

Prostate cancer survival is dependent on season of diagnosis. Prostate (2007) 0.99

Seasonal variations of cancer incidence and prognosis. Dermatoendocrinol (2010) 0.98

Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries. Scand J Public Health (2010) 0.94

Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharm Res (2010) 0.93

Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci (2004) 0.92

The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim Biophys Acta (2004) 0.91

Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci (2002) 0.91

Beneficial effects of UV radiation other than via vitamin D production. Dermatoendocrinol (2012) 0.91

Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release (2005) 0.90

Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes (2010) 0.89

In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane. Photochem Photobiol (2007) 0.88

Radiosensitization of tumours by porphyrins. Cancer Lett (2005) 0.88

Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol (2006) 0.86

Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer (2003) 0.85

Photodegradation of 5-methyltetrahydrofolate in the presence of Uroporphyrin. J Photochem Photobiol B (2008) 0.85

Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol (2006) 0.85

Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B (2010) 0.84

Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol (2005) 0.84

The relationship between UV exposure and incidence of skin cancer. Photodermatol Photoimmunol Photomed (2014) 0.84

The vitamin D status among Tibetans. Photochem Photobiol (2009) 0.84

Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett (2006) 0.83

Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem Photobiol Sci (2008) 0.83

Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects. J Photochem Photobiol B (2009) 0.83

Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr (2010) 0.83

Reflectance spectra of pigmented and nonpigmented skin in the UV spectral region. Photochem Photobiol (2004) 0.83

Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps. BMC Dermatol (2007) 0.82

Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol (2010) 0.82

The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid. J Photochem Photobiol B (2006) 0.82

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer. Cancer Lett (2003) 0.82

Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis. Photodiagnosis Photodyn Ther (2009) 0.82

Photodegradation of 5-methyltetrahydrofolate: biophysical aspects. Photochem Photobiol (2007) 0.82

Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation. Dermatoendocrinol (2010) 0.82

5-Methyltetrahydrofolate can be photodegraded by endogenous photosensitizers. Free Radic Biol Med (2009) 0.82

UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden. Photochem Photobiol Sci (2011) 0.82

Sun and sun beds: inducers of vitamin D and skin cancer. Anticancer Res (2009) 0.82

Vitamin D status in healthy Romanian caregivers and risk of respiratory infections. Public Health Nutr (2012) 0.81

Sun beds and cod liver oil as vitamin D sources. J Photochem Photobiol B (2008) 0.81

Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum. Biochim Biophys Acta (2004) 0.81

Influenza, solar radiation and vitamin D. Dermatoendocrinol (2009) 0.81

Vitamin D, sun, sunbeds and health. Public Health Nutr (2011) 0.81

A new method for photodynamic therapy of melanotic melanoma -- effects of depigmentation with violet light photodynamic therapy. J Environ Pathol Toxicol Oncol (2007) 0.80

Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model. Photochem Photobiol (2008) 0.80

pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures. Bioelectrochemistry (2003) 0.80

Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B (2010) 0.80

Sun exposure and melanomas on sun-shielded and sun-exposed body areas. Adv Exp Med Biol (2014) 0.80

Erythrocytes-the 'house elves' of photodynamic therapy. Photochem Photobiol Sci (2004) 0.80

Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions. J Photochem Photobiol B (2004) 0.79

Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol (2002) 0.79

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy. Photochem Photobiol Sci (2010) 0.79

Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients. Melanoma Res (2012) 0.79

Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses (2007) 0.78

Immediate pigment darkening: its evolutionary roles may include protection against folate photosensitization. FASEB J (2011) 0.78

Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study. Biochim Biophys Acta (2012) 0.78

Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer. Int J Cancer (2011) 0.78